Speaker details

Biography

Harry has broad transactional experience in public and private M&A, equity capital markets and other corporate transactions. He also advises listed clients on a wide range of corporate governance matters, including activism situations. Harry sits on the legal panel of the Investor Forum, having advised on its establishment, and has authored several publications on subjects relevant to his practice. Harry heads our international committee which has oversight of our relationships with international law firms. Harry also co-heads our consumer and retail sector group. Recent highlights include advising: • Valderrama Limited, a joint venture company controlled by SPWOne V Limited and Castelnau Group Limited on its proposed acquisition of Dignity plc, the UK’s leading end-of-life services business, with an implied enterprise value of £789m; • Hyve, the next-generation global events business, on its acquisition of 121 Group, a market-leading omnichannel meetings programme organiser focused on the mining sector, including on the related equity placing to fund the acquisition; • NortonLifeLock Inc., a NASDAQ-listed provider of consumer Cyber Safety solutions, on its recommended cash and stock merger with FTSE100 company Avast plc, a leading global cybersecurity provider, in a transaction attributing an enterprise value to Avast of up to $9.2bn; • Jazz Pharmaceuticals plc, a biopharmaceutical company based in Ireland, on its acquisition of GW Pharmaceuticals plc for a total consideration of $7.2bn, comprising cash of $6.55bn and stock of $650m, by way of a UK scheme of arrangement;